The Current Ratio as of December 2025 (TTM) for Rekah Pharmaceutical Industry Ltd. (REKA.TA) is 1.57

According to Rekah Pharmaceutical Industry Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.57. This represents a change of 5.65% compared to the average of 1.49 of the last 4 quarters.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Historical Current Ratio (quarterly & annually)

How has REKA.TA Current Ratio performed in the past?

The mean historical Current Ratio of Rekah Pharmaceutical Industry Ltd. over the last ten years is 2.13. The current 1.57 Current Ratio has changed 7.30% with respect to the historical average. Over the past ten years (40 quarters), REKA.TA's Current Ratio was at its highest in in the March 2016 quarter at 2.74. The Current Ratio was at its lowest in in the September 2024 quarter at 1.43.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Rekah Pharmaceutical Industry Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Average Current Ratio

How has REKA.TA Current Ratio performed in the past?

The current Current Ratio of Rekah Pharmaceutical Industry Ltd. (REKA.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rekah Pharmaceutical Industry Ltd. (REKA.TA) Current Ratio vs. Peers

How is REKA.TA’s Current Ratio compared to its peers?

Rekah Pharmaceutical Industry Ltd.’s Current Ratio is greater than G.F.C Green Fields Capital Ltd. (1.32), greater than Kadimastem Ltd (0.02), less than Seach Medical Group Ltd (3.34), greater than Together Pharma Ltd (1.11), less than Pluri Inc. (4.81), greater than Nissan Medical Industries Ltd (1.01), greater than Tikun Olam-Cannbit Pharmaceuticals Ltd (0.20), less than Geffen Residence & Renewal Ltd (5.33), less than Dna Group (T.R.) Ltd (48.83), less than Enlivex Therapeutics Ltd. (6.43),

Build a custom stock screener for Rekah Pharmaceutical Industry Ltd. (REKA.TA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rekah Pharmaceutical Industry Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rekah Pharmaceutical Industry Ltd. (REKA.TA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rekah Pharmaceutical Industry Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.